Elevated levels of inflammatory markers, such as C-reactive protein, are well documented in people with depression. Few studies have examined whether the association between inflammation and depression is symptom specific, and differs according to antidepressant treatment. Using data from the English Longitudinal Study of Ageing (N = 5909), cross-sectional analyses revealed a significant dose-response association between C-reactive protein and the symptoms of fatigue (P < 0.001), restless sleep (P = 0.03), low energy (P = 0.02) and feeling depressed (P = 0.04), but not other symptoms. These associations were absent in users of anti-depressant medication. Our findings suggest the C-reactive protein-depression association is symptom-specific and modified by antidepressant treatment.
Authors
UCL Research Department of Epidemiology and Public Health
Mika Kivimaki
James White
Markus Jokela
Journal article details
- DOI
- 10.1016/j.bbi.2016.08.012
- Publisher
- Elsevier
- Issue
- Volume 61, August 2016, pages 27-30
Suggested citation
Batty, D et al. (2016). 'Association of Inflammation with Specific Symptoms of Depression in a General Population of Older People: The English Longitudinal Study of Ageing.' 61(2016), pp.27–30.
More from IFS
Understand this issue
Retirement is not always a choice that workers can afford to make
6 November 2023
Why inheritance tax should be reformed
18 January 2024
Pensions are far from broken but could still use a fix
18 December 2023
Policy analysis
The past and future of NHS waiting lists in England
29 February 2024
Recent trends in and the outlook for health-related benefits
19 April 2024
4.2 million working-age people now claiming health-related benefits, could rise by 30% by the end of the decade
19 April 2024
Academic research
The consequences of miscarriage on parental investments
22 March 2024
The menopause "penalty"
18 March 2024
Evaluating pricing health insurance in lower-income countries: A field experiment in India
14 March 2024